Subscribe Now
  • Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. Biotech Industry

Biotech Industry

Page 2 of 2

Photo of CytoSeek CEO Carolyn Porter
Tech

New venture fund backs CytoSeek, a startup looking to give “superpowers” to cancer-fighting T-cells

By Jeremy Kahn
March 16, 2021
A robot arm moving vials in a drug research lab.
Tech

Money is pouring in to A.I.-assisted drug discovery, while fewer A.I. startups are getting VC backing

By Jeremy Kahn
March 3, 2021
DeepMind’s new protein-folding A.I. is already helping in the fight against COVID-19
Health

DeepMind’s new protein-folding A.I. is already helping in the fight against COVID-19

By Jeremy Kahn
November 30, 2020
Paul Hudson, chief executive officer of Sanofi, gestures as he speaks during a panel session on the sidelines of the China International Import Expo (CIIE) in Shanghai, China, on Tuesday, Nov. 5, 2019. The CIIE -- now in its second year -- is designed to showcase the countrys desire to shift its economy toward consumption by buying more foreign goods. Photographer: Qilai Shen/Bloomberg via Getty Images
International

Why Sanofi Is Buying a U.S. Cancer Biotech for Nearly 3 Times Its Market Value

By James Paton and Bloomberg
December 9, 2019
Herceptin Approved For Treatment Of Scottish Breast Cancer Patients
Health

Samsung’s Biotech Unit Is Seeking Europe Approval for Its Copy of This Drug

By Reuters and Michelle Toh
October 4, 2016
How a Biotech Turned a Bust Into a Hit
Health

How a Biotech Turned a Bust Into a Hit

By Jennifer Alsever
September 26, 2016
WAKSAL
Health

This Ex-Con’s Startup Is Drowning in Debt. So Why Are People Investing?

By Damian Garde and STAT News
July 26, 2016
Scientists Think a Simple Paper Strip Could Tell if You Have Cancer or Malaria
Health

Scientists Think a Simple Paper Strip Could Tell if You Have Cancer or Malaria

By Sy Mukherjee
June 30, 2016
Big Pharma Innovation in Small Places

Big Pharma Innovation in Small Places

By Jennifer Alsever
May 13, 2016
The 5 Best Performing Biotech Stocks in 2016
Health

The 5 Best Performing Biotech Stocks in 2016

By Laura Lorenzetti
March 15, 2016

Most Popular

  • Economy
    An unusual Fed ‘rate check’ triggered a free fall in the U.S. dollar and investors are fleeing into gold
    By Jim Edwards
  • Success
    Despite running $75 billion automaker General Motors, CEO Mary Barra still responds to ‘every single letter’ she gets...
    By Preston Fore
  • Commentary
    Yes, you're getting a bigger tax refund. Your kids won't thank you for the $3 trillion it's adding to the deficit
    By Daniel Bunn
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Coins2Day
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.